Lumosa Therapeutics Co., Ltd. (6535)
Market Closed
11 Aug, 05:30
TWSE 
JPX Primary TWSE NT$
92. 10
+1.3
+1.4317%
NT$
- Market Cap
- P/E Ratio
104% Div Yield
165,459 Volume
- Eps
NT$ 90.8
Previous Close Want to track 6535 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Lumosa Therapeutics Co., Ltd. (6535) Statistics
Valuation metrics
Market Cap -
Enterprise value 15.08B
Trailing P/E (ttm) -42.37
Forward P/E -
PEG ratio 1.62
Price/Sales (ttm) 485.64
Price/Book (mrq) 10.86
Enterprise Value/Revenue 480.07
Enterprise Value/EBITDA -53.22
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 144.07K
Average volume (90 days) 204.28K
Price summary
52-Week low 85.8
52-Week high 329.5
Beta -
50-Day moving average 95.13
200-Day moving average 130.93
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 30 Jul 2026
Ex-Dividend Date 30 Jul 2026
Last split factor 501:500
Last split Date 20 Sep 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -11.33%
Operating margin -9.34%
Operational effectiveness
Return on assets -0.23%
Return on equity -0.23%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.19
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.14
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4.5
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 7.37%
Book value per share (mrq) 8.44
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
